OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Organ Transplantation is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?	72
Editorial: Organ Preservation Revolution: the future is revisiting the past through a different lens	37
Delayed graft function: current status and future directions	33
HLA-DQ antibodies in alloimmunity, what makes them different?	29
The perspective for next-generation lung replacement therapies: functional whole lung generation by blastocyst complementation	28
Using organ perfusion to optimize donor livers	27
Deceased donors with multidrug-resistant organisms: implications and future directions	25
Overview of pregnancy in solid-organ transplantation	19
Urine CXCL10 as a biomarker in kidney transplantation	19
Obesity and kidney transplantation	18
Modifying organs with gene therapy and gene modulation in the age of machine perfusion	18
Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients	18
Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?	18
What is needed to ensure long-term sustainability for the field of vascularized composite allotransplantation?	16
Equity in liver transplantation: are we any closer?	16
Update on combined heart and liver transplantation: evolving patient selection, improving outcomes, and outstanding questions	15
The ethics of donation after circulatory death organ recovery: an overview of new considerations arising from procurement practice and policy changes	15
Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease	14
Language and cultural concordance to promote equity in organ transplantation for Hispanics with limited English proficiency	13
Establishing an upper extremity transplantation program: lessons learnt over 12 years	13
Respiratory viral infections including COVID-19 in solid organ transplantation	13
Novel agents in the treatment of invasive fungal infections in solid organ transplant recipients	12
Beyond donation to organ utilization in the UK	12
Management of the sensitized heart transplant candidate	11
Cardiac evaluation of the liver transplant candidate	11

The sex disparity in liver transplantation	11
Regulatory dendritic cell therapy in organ transplantation	11
A cystic fibrosis patient	11
Donor-derived infections in solid organ transplant recipients	10
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation	10
Machine perfusion in liver transplantation: recent advances and coming challenges	10
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients	10
A review of transplant infectious diseases and pediatric transplant infectious diseases curriculum	10
Defining chronic rejection in vascularized composite allografts – do we have reliable surrogates to look for?	9
Future directions for xenotransplantation in lungs	9
Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation	8
The road to xenotransplantation	8
Ethical issues in organ procurement: donation after normothermic regional perfusion in liver transplantation	8
Living liver donor pain management	8
Grasping time – longevity of vascularized composite allografts	8
Editorial introductions	8
Social support and transplantation	8
Ethical considerations in lung re-transplantation	8
Lung preservation: from perfusion to temperature	8
Unraveling the spectrum of airway complications following lung transplantation: a comprehensive overview	7
The role of living donor liver transplantation in colorectal cancer liver metastases	7
Normothermic regional perfusion for donation after circulatory death donors	7
Editorial introductions	7
Pediatric intestinal rehabilitation	7
Social and biologic determinants in lung transplant allocation	7
Thoraco-abdominal normothermic regional perfusion for thoracic transplantation in the United States: current state and future directions	7
Adherence in transplantation	6
Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics	6
Expanding MELD exceptions for colorectal liver metastasis: data and policy	6
Controlling infections in hospitalized pretransplant candidates	6
Liver transplantation for intrahepatic cholangiocarcinoma: who, when and how	6
Optimizing cardiac status in the preliver transplant candidate	6
Advances in desensitization for human leukocyte antigen incompatible kidney transplantation	6
Optimizing the pediatric transplant candidate	6
Editorial introduction	6
Kidney organ allocation: reducing discards	6
Editorial introductions	6
Multidrug-resistant organisms in lung transplant: a narrative review	6
Editorial introductions	6
Normothermic regional perfusion procurement for abdominal organ donors: techniques and troubleshooting	5
Machine wars and policy provisions: how the landscape of organ procurement and allocation is changing in the United States	5
Viability assessment of the liver during ex-situ machine perfusion prior to transplantation	5
Postoperative surgical complications after pediatric kidney transplantation in low weight recipients (<15 kg): a systematic review	5
Acute complication posttransplant: primary allograft dysfunction	5
Mind the gaps: reframing patient selection and organ allocation in liver transplantation	5
Bacterial infections in solid organ transplant recipients	5
Innovative surgical techniques in the intestine and multivisceral transplant	5
Editorial introductions	5
Use of belatacept in kidney transplantation: what's new?	5
The history of ethical principles in liver transplant organ allocation in the United States: how historical and proposed allocations system fare in balancing utility vs. urgency and justice vs. pragma	5

Editorial introduction	4
The current state of tolerance induction in vascularized composite allotransplantation	4
Editorial introduction	4
The importance of equity in transplant oncology	4
Novel therapies for treatment of antibody-mediated rejection of the kidney	4
Stroke and kidney transplantation	4
Coagulation management during liver transplantation: monitoring and decision making for hemostatic interventions	4
The Liver Frailty Index: a model for establishing organ-specific frailty metrics across all solid organ transplantation	4
Transplant oncology: keeping the patient's perspective in mind	4
Normothermic machine perfusion for liver transplantation: current state and future directions	4
Improving liver transplant outcomes with transplant-omics and network biology	4
Progress towards permanent respiratory support	4
Editorial introductions	4
Exercise training in solid organ transplant candidates and recipients	4
Depression in transplantation	4
Pain management for liver transplant recipients	3
How to maximize graft survival	3
Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy	3
Beyond donation to organ utilization in the USA	3
Pediatric intestine and multivisceral transplant	3
Update on Covid-19: vaccines, timing of transplant after COVID-19 infection and use of positive donors	3
Fueling the success of transplantation through nutrition: recent insights into nutritional interventions, their interplay with gut microbiota and cellular mechanisms	3
Collaborative care models in adult congenital heart disease transplant	3
Ethical issues in solid organ transplantation: transfusion-free transplantation in Jehovah's witness patients	3
Squaring the Circle. Brain death and organ transplantation	3
Shorter durations of antibiotic therapy in organ transplant	3
Antibody-mediated rejection: prevention, monitoring and treatment dilemmas	3
Renal transplantation: the last iteration of the rest of the world	3
Molecular profiling in the management of hepatocellular carcinoma	3
Ensuring equity in psychosocial risk assessment for solid organ transplantation: a review	3
Mitochondria and ischemia reperfusion injury	3
Liver transplantation and portal vein tumour thrombus: futile enterprise?	3
Utilization of hepatitis C virus-positive donors in kidney transplantation	3
Editorial introductions	3
Editorial: Mechanistic and therapeutic advances in antibody-mediated rejection: reasons to be optimistic	3
Primary graft dysfunction after lung transplantation	3
Approaches to pretransplant vaccination	3